Search

Your search keyword '"Jesus Campagna"' showing total 29 results

Search Constraints

Start Over You searched for: Author "Jesus Campagna" Remove constraint Author: "Jesus Campagna" Publication Year Range Last 50 years Remove constraint Publication Year Range: Last 50 years
29 results on '"Jesus Campagna"'

Search Results

1. Pharmacological inhibition of nSMase2 reduces brain exosome release and α-synuclein pathology in a Parkinson’s disease model

2. High-throughput screening identifies modulators of sarcospan that stabilize muscle cells and exhibit activity in the mouse model of Duchenne muscular dystrophy

3. A Small-Molecule Approach to Restore a Slow-Oxidative Phenotype and Defective CaMKIIβ Signaling in Limb Girdle Muscular Dystrophy

5. Integrated Multiomics Analysis of Salivary Exosomes to Identify Biomarkers Associated with Changes in Mood States and Fatigue

6. Dual Neutral Sphingomyelinase-2/Acetylcholinesterase Inhibitors for the Treatment of Alzheimer’s Disease

8. Exosomal tau with seeding activity is released from Alzheimer's disease synapses, and seeding potential is associated with amyloid beta

9. Correction to: Pharmacological inhibition of nSMase2 reduces brain exosome release and α-synuclein pathology in a Parkinson’s disease model

10. Pharmacological inhibition of nSMase2 reduces brain exosome release and α-synuclein pathology in a Parkinson’s disease model

11. A Small-Molecule Approach to Restore a Slow-Oxidative Phenotype and Defective CaMKIIβ Signaling in Limb Girdle Muscular Dystrophy

12. High-throughput screening identifies modulators of sarcospan that stabilize muscle cells and exhibit activity in the mouse model of Duchenne muscular dystrophy

13. A small molecule ApoE4-targeted therapeutic candidate that normalizes sirtuin 1 levels and improves cognition in an Alzheimer’s disease mouse model

14. C O bond formation in a microfluidic reactor: high yield S N Ar substitution of heteroaryl chlorides

15. Synthesis of Fused Indolines by Interrupted Fischer Indolization in a Microfluidic Reactor

16. O5‐06‐06: NORMALIZATION OF HIPPOCAMPAL SIRTUIN 1 LEVELS IN A MURINE APOLIPOPROTEIN E4‐5XFAD MODEL OF AD RESTORES COGNITIVE FUNCTION

17. Suppression of tau propagation using an inhibitor that targets the DK-switch of nSMase2

18. P4-057: PURIFICATION AND CHARACTERIZATION OF SUBPOPULATIONS OF EXTRACELLULAR VESICLES FROM AD AND PD BRAIN AND THEIR SUPPRESSION BY NSMASE2 INHIBITORS

19. Nanoscale Extracellular Vesicle Analysis in Alzheimer’s Disease Diagnosis and Therapy

20. sAβPPα is a Potent Endogenous Inhibitor of BACE1

21. Evaluation of an Allosteric BACE Inhibitor Peptide to Identify Mimetics that Can Interact with the Loop F Region of the Enzyme and Prevent APP Cleavage

22. Deformable Nanovesicles Synthesized through an Adaptable Microfluidic Platform for Enhanced Localized Transdermal Drug Delivery

23. P2-176: IDENTIFICATION OF AN EXPERIMENTAL DRUG THAT ENHANCES BRAIN SIRTUIN 1 LEVELS AND IMPROVES COGNITION AS A POTENTIAL NEW THERAPEUTIC FOR AD

24. AβPP-Selective BACE Inhibitors (ASBI): Novel Class of Therapeutic Agents for Alzheimer's Disease

25. Screening for Small Molecule Inhibitors of Statin-Induced APP C-terminal Toxic Fragment Production

26. P4‐061: Amyloid Precursor Protein C‐Terminal Cleavage Resulting in the Toxic C31 Peptide: Stimulation of Cleavage with Cerevastatin and Inhibition and Cell Viability Rescue Using Small Molecules

28. P1‐089: Targeting trka inhibition in Alzheimer's disease therapy

29. The multi-functional drug tropisetron binds APP and normalizes cognition in a murine Alzheimer’s model

Catalog

Books, media, physical & digital resources